共 50 条
- [21] Real-world efficacy of relatlimab and nivolumab in advanced or resectable melanomaANNALS OF ONCOLOGY, 2024, 35 : S731 - S731Karapetyan, L.Aflatooni, S.Ward, K.Withycombe, B.Kalos, D.Mo, Q.Eroglu, Z.Brohl, A. S.Markowitz, J.Tarhini, A.Messina, J.Tsai, K. Y.Perez, M.Zager, J. S.Sarnaik, A.Neves, R. I.Sondak, V.Khushalani, N. I.
- [22] Clinical management and outcomes of patients with advanced renal cell carcinoma (aRCC) treated with nivolumab plus ipilimumab (N plus I): A real-world studyANNALS OF ONCOLOGY, 2023, 34 : S1020 - S1020Geldart, T. R.Pickering, L. M.Sharma, A.Scott, D.Parikh, O. A.Coleman, S.Dhokia, P.Hale, M.Vaz, L.
- [23] REAL-WORLD OUTCOMES OF PATIENTS WITH RESECTED STAGE IIIA MELANOMA TREATED WITH ADJUVANT NIVOLUMAB IN A US COMMUNITY SETTINGJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A451 - A451Samlowski, WolframChan, PhillipPavlick, AnnaMoser, JustinRobert, NicholasPoreta, TaylaMoshyk, AndriySakkal, LeonPalaia, JennellNiehoff, NicoleRajkumar, JonathanAmin, Asim
- [24] Real-world treatment patterns and clinical outcomes among subgroups of BRAF-positive metastatic melanoma patients treated with dabrafenib plus trametinib.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Eroglu, ZeynepTang, JacksonByrne, ClareConnolly, LucyShah, RohanThach-Giao Truong
- [25] OUTCOMES OF TREATMENT FOR ADVANCED GASTRIC CANCER IN KOREAN PATIENTS TREATED WITH RAMUCIRUMAB plus PACLITAXEL: A NATIONWIDE REAL-WORLD DATAVALUE IN HEALTH, 2024, 27 (12) : S607 - S607Byun, J. H.Lee, E. J.Cho, D. Y.Jeong, S. J.Kim, S. Y.Kim, D. S.
- [26] Real-world treatment patterns and overall survival in previously treated advanced renal cell carcinoma patients receiving nivolumab in the UK.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Waddell, TomFife, KateGriffiths, RichardSharma, AnandDhokia, PoonamGordon, JasonGroves, LaraHurst, MichaelSugrue, DanielTsang, CarmenMckenna, StephenHoughton, JohnCarroll, Robert
- [27] Real-World Treatment Patterns and Outcomes in Patients With Myelofibrosis Treated With Pacritinib in the United StatesCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S431 - S431Marrone, MichaelGeller, RobertOladapo, AbiolaSuthar, PurviVasudevan, AnupamaVredenburg, MichaelZeng, JiaRampal, RaajitMascarenhas, John
- [28] Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United StatesJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Marrone, MichaelGeller, RobertOladapo, AbiolaSuthar, PurviVasudevan, AnupamaVredenburg, MichaelZeng, JiaRampal, RaajitMascarenhas, John
- [29] Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabBLOOD ADVANCES, 2024, 8 (09) : 2248 - 2258Chandrakasan, ShanmuganathanJordan, Michael B.Baker, AshleyBehrens, Edward M.Bhatla, DeepikaChien, MayEckstein, Olive S.Henry, Michael M.Hermiston, Michelle L.Hinson, Ashley P.Leiding, Jennifer W.Oladapo, AbiolaPatel, Sachit A.Pednekar, PritiRay, Anish K.Saldana, Blachy DavilaSarangi, Susmita N.Walkovich, Kelly J.Yee, John D.Zoref-Lorenz, AdiAllen, Carl E.
- [30] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in EnglandBRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5Verleger, KatharinaHertel, NadineSolem, CaitlynPenrod, John R.Macahilig, CynthiaLuo, LinlinCrawford, S. Michael